ArticleNature communications2026
Cyanine-modified ssODNs enhance CRISPR-Cas9 HDR in stem cell embryo models via chromatin and chemical modulation.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
While CRISPR-Cas9 has transformed biomedical research, precise genome editing via homology-directed repair (HDR) remains limited by low efficiency and cytotoxicity, particularly in sensitive systems. Here, we show that simple 5' cyanine modifications of single-stranded oligodeoxynucleotides (ssODNs) markedly enhance HDR efficiency across human stem cell models, providing a 2-3-fold survival advantage. This approach enables in situ HDR in 3D human embryo models (blastoids), achieving up to 30% HDR-a 2.5-3-fold improvement over unmodified ssODNs-without compromising viability or developmental potential. Edited blastoids recapitulate key implantation features, including epiblast outgrowths surrounded by hypoblasts and trophoblasts. Mechanistically, enhanced HDR is associated with upregulation of HDR-related genes, including linker histone H1.0, which binds 5'Cy5-ssODNs and promotes HDR. Additionally, 5'Cy5 increases stability and nuclear availability of ssODNs. Molecular dynamics and free energy analyses suggest that 5'Cy5 promotes compact, circular-like conformations, validated by atomic force microscopy, and enhances donor-target duplex stability. Together, these findings establish cyanine-modified ssODNs as a simple, biocompatible strategy to improve precise genome editing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.